EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. - Wikidata - awgldk - TriplyDB

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

http://www.wikidata.org/entity/Q37158767

about

BCG strain S4-Jena: An early BCG strain is capable to reduce the proliferation of bladder cancer cells by induction of apoptosis Genetic susceptibility to distinct bladder cancer subphenotypes Aberrantly expressed microRNAs in the context of bladder tumorigenesis Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladder Urine survivin as a diagnostic biomarker for bladder cancer: a systematic review Effects of fluorescent light-guided transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis A Multimodal Imaging Approach for Longitudinal Evaluation of Bladder Tumor Development in an Orthotopic Murine Model.Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS).Identification of S100A8-correlated genes for prediction of disease progression in non-muscle invasive bladder cancer Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer.Confocal laser endomicroscopy for the diagnosis of urothelial bladder neoplasia: a technology of the future?HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer.Bacillus Calmette Guerin induces fibroblast activation both directly and through macrophages in a mouse bladder cancer model.FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy.Effects of programmed death-ligand 1 expression on OK-432 immunotherapy following transurethral resection in non-muscle invasive bladder cancer Identification of C16orf74 as a marker of progression in primary non-muscle invasive bladder cancer.mRNA Expression of S100A8 as a Prognostic Marker for Progression of Non-Muscle-Invasive Bladder Cancer 2-micrometer continuous wave laser treatment for multiple non-muscle-invasive bladder cancer with intravesical instillation of epirubicin.Population-based analyses of radical cystectomy and urinary diversion for bladder cancer in northern Italy.ProEx C as Diagnostic Marker for Detection of Urothelial Carcinoma in Urinary Samples: A Review Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy.Patterns of care for early stage bladder cancer.Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial.Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non-muscle invasive bladder cancer.Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer.ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder Randomized controlled trial of oxybutynin extended release versus placebo for urinary symptoms during intravesical Bacillus Calmette-Guérin treatment.Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Guérin.Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis.Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.Usefulness of urine cytology as a routine work-up in the detection of recurrence in patients with prior non-muscle-invasive bladder cancer: practicality and cost-effectiveness.Selection of microsatellite markers for bladder cancer diagnosis without the need for corresponding blood.MicroRNA-1 in Cardiac Diseases and Cancers Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis.Saudi oncology society and Saudi urology association combined clinical management guidelines for urothelial urinary bladder cancer.Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer.Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature.The natural history of secondary muscle-invasive bladder cancer.

P2860

Q24604781-04964452-B3AB-47B7-855E-B55932610017 Q24624419-DAE6BE66-E0E2-4F01-97D1-102CDB2C405B Q26744152-8C7023A1-4472-4682-9B8C-6B638F7B3824 Q26747775-409D7AA3-4F9C-4F58-8D85-944ECF5EAE62 Q26828933-9DC620D5-6F48-4A6C-A35B-CA291E895148 Q26866103-6A03671D-160F-4AAF-B17E-8C3A8D0B868C Q30375752-E52FAA29-42A4-4800-890B-308A1F83B3AF Q30596342-0CD34ECC-62EB-4010-9135-9CE31C0B629F Q33526078-333CABC9-02FA-4807-ABB5-FA195BA52025 Q33650639-805E2363-538B-41F5-9852-750F121DDBE6 Q33657242-63361060-DC64-4408-9675-1F35C1A3C7F9 Q33688043-50BF76DE-FD22-47BF-ACA6-A4D3499199BE Q33735922-68B9DD08-2937-48BB-A181-5850560D9320 Q33745140-301DEECA-016A-487C-939D-A62A1771BD2A Q33751253-68F00DF1-2DBC-4E86-93AD-D948312482FA Q33784739-23DD2537-8A26-4746-9CE3-9154556D3DA8 Q33792824-A5DD55A3-8AEF-42E7-96E0-AA2090B69F22 Q33799524-1980928F-FE27-4B0B-B545-4AA0BCAD2720 Q33820181-483D89AA-B832-44A5-80C4-1B2FD56A61C0 Q33820634-E3B98D12-DCB0-43BE-9A23-2F8B6D591174 Q33869233-A9F8180D-40B7-48A7-A181-92B6E54F22C2 Q33875940-17D813A2-4FFA-4EC6-8A06-08DD9719D7C6 Q33927694-1C173D5E-E6BA-49E0-8BFD-31855A201A43 Q33945057-F7A0AC97-3F69-43AE-8E06-098C07487D4E Q33959824-6237C9E9-A2C8-4F10-8E91-23C00554BCB3 Q33976936-7C4513B2-8CD2-4527-B88A-5E09BEC0827E Q34059983-AA422C9E-E93C-429A-BEE5-720DFC7A2C62 Q34115106-6C9FEB5C-BE85-4B1A-A52B-8D076A6D02F5 Q34305503-BEC64F92-F74B-4846-AB8C-E408B8EFDFFD Q34318570-D4C03393-2CFE-4DEB-B024-56380B6C08AF Q34346668-D0FEB68D-F407-486C-8C7A-FF930A764216 Q34346854-D1300A13-BA65-4E76-B912-E0FC9616B9C1 Q34395643-7E87007A-00F5-411F-A2EE-60BE707EA4F3 Q34412493-D57224F4-CA36-4022-8F29-A1C7E6293D7C Q34416939-889831AB-57CB-4248-8EAA-96893ADE0070 Q34437299-1F568081-C67D-4335-A7AD-E09317787E11 Q34441297-70F3E38E-4BA0-4274-A82C-6706313B1742 Q34539958-92052233-534D-49CA-AF2D-F7D387019BA1 Q34579038-B723CFA3-1AAD-4072-9CDD-92163629E542 Q34711282-FAA4A3C3-646A-4B8B-8C38-24481C726768

P2860

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

http://www.wikidata.org/entity/Q37158767

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

@en

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

@nl

type

label

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

@en

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

@nl

prefLabel

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

@en

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

@nl

P1433

Q37158767-B64F2153-414F-4049-9F0A-D34C2E6B9747

P1476

Q37158767-04E24C11-3643-4D7D-A846-171CB2AC6918

P2093

Q37158767-1F8EB8EE-1C48-4034-A8D0-7D82406BCFE1

Q37158767-40CD670B-826C-430B-859B-866F4874AB2C

Q37158767-4A85B179-731E-4480-AD3F-DA41549756D1

Q37158767-631DB668-07F2-4D11-8761-EFC0D2BACF69

Q37158767-85DEF650-103F-44CF-8B45-1FE9FBD6C90F

Q37158767-DC1808CC-8A21-4160-BA99-53D900D773A0

Q37158767-EBAF415B-77A8-4D77-9E9B-F482D4C711EA

P304

Q37158767-CC4958D7-C594-4114-AC70-D961A4A1071B

P31

Q37158767-FA41B669-05A6-4B05-BD38-52457E8A28B7

P356

Q37158767-6084A203-B6CD-4505-A48F-9A8B9D3A748D

P407

Q37158767-1F9FFE05-7EF8-4F32-9692-10054A085C6C

P433

Q37158767-3EE28998-C80E-4D3C-BC31-2CD7A83F3F8B

P478

Q37158767-A5EADFED-6DAA-40E9-AE9D-97C294AE17E9

P577

Q37158767-939430DB-AFA3-4F8C-85A7-27C002422D7C

P5875

Q37158767-30CA3B8A-CA31-494F-8E79-CEE938FF7158

P698

Q37158767-148459D6-33AA-4BD3-98B0-AED3729A23F3

P356

J.EURURO.2008.04.051

P1433

European Urology

P1476

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

@en

P2093

Andreas Böhle

http://www.w3.org/2001/XMLSchema#string

Eero Kaasinen

http://www.w3.org/2001/XMLSchema#string

European Association of Urology (EAU)

http://www.w3.org/2001/XMLSchema#string

Juan Palou-Redorta

http://www.w3.org/2001/XMLSchema#string

Marko Babjuk

http://www.w3.org/2001/XMLSchema#string

Richard Sylvester

http://www.w3.org/2001/XMLSchema#string

Willem Oosterlinck

http://www.w3.org/2001/XMLSchema#string

P304

303-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EURURO.2008.04.051

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5382340

http://www.w3.org/2001/XMLSchema#string

P698

18468779

http://www.w3.org/2001/XMLSchema#string